Filana Therapeutics, Inc. (FLNA)
0.47
+0.04
(+10.56%)
USD |
NASDAQ |
Nov 16, 16:00
0.47
0.00 (0.00%)
After-Hours: 20:00
Filana Therapeutics Price to Book Value : 0.4059 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 0.4059 |
| November 13, 2026 | 0.3671 |
| November 12, 2026 | 0.3869 |
| November 11, 2026 | 0.4163 |
| November 10, 2026 | 0.4165 |
| November 09, 2026 | 0.4251 |
| November 06, 2026 | 0.3909 |
| November 05, 2026 | 0.3895 |
| November 04, 2026 | 0.494 |
| November 03, 2026 | 0.5132 |
| November 02, 2026 | 0.4845 |
| October 30, 2026 | 0.5372 |
| October 29, 2026 | 0.5682 |
| October 28, 2026 | 0.5619 |
| October 27, 2026 | 0.5599 |
| October 26, 2026 | 0.5283 |
| October 23, 2026 | 0.5488 |
| October 22, 2026 | 0.5649 |
| October 21, 2026 | 0.5694 |
| October 20, 2026 | 0.5946 |
| October 19, 2026 | 0.589 |
| October 16, 2026 | 0.6075 |
| October 15, 2026 | 0.657 |
| October 14, 2026 | 0.6318 |
| October 13, 2026 | 0.642 |
| Date | Value |
|---|---|
| October 12, 2026 | 0.6645 |
| October 09, 2026 | 0.7054 |
| October 08, 2026 | 0.7026 |
| October 07, 2026 | 0.7044 |
| October 06, 2026 | 0.7556 |
| October 05, 2026 | 0.7512 |
| October 02, 2026 | 0.8039 |
| October 01, 2026 | 0.8334 |
| September 30, 2026 | 0.7651 |
| September 29, 2026 | 0.7023 |
| September 28, 2026 | 0.648 |
| September 25, 2026 | 0.5681 |
| September 24, 2026 | 0.5869 |
| September 23, 2026 | 0.6608 |
| September 22, 2026 | 0.7822 |
| September 21, 2026 | 0.5616 |
| September 18, 2026 | 0.5514 |
| September 17, 2026 | 0.5468 |
| September 16, 2026 | 0.5196 |
| September 15, 2026 | 0.529 |
| September 14, 2026 | 0.5459 |
| September 11, 2026 | 0.5868 |
| September 10, 2026 | 0.6143 |
| September 09, 2026 | 0.6143 |
| September 08, 2026 | 0.6054 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| CorMedix, Inc. | 0.8297 |
| Eloxx Pharmaceuticals, Inc. | 1.269 |
| Breakthrough Chemistry, Inc. | 1.592 |
| BioStem Technologies, Inc. | 0.9777 |
| Cardiac Biotech Solutions, Inc. | -- |
Price to Book Value Related Metrics
| Price | 0.47 |
| Earnings Yield | -185.7% |
| Market Cap | 23.53M |